New York, New York - April 01, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement providing a ...
New York, New York - March 17, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement outlining the ...
New York, New York - March 25, 2026 - PRESSADVANTAGE - Silverback AI Chatbot has released an announcement detailing its ...
In a hypothetical clash of titans, a king cobra and a silverback gorilla face off. The cobra relies on potent venom and agility, while the gorilla boasts immense strength and intelligence. Despite the ...
The case alleges that the Offering Documents and Silverback and its senior executives made misleading statements to investors and failed to disclose that: (i) Silverback's lead product candidate ...
Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report. The company reported ...
- Strategic realignment to focus resources on SBT8230 for chronic hepatitis B virus (cHBV) and discovery pipeline by discontinuing SBT6050 and SBT6290 clinical oncology programs - On track to complete ...
As Silverback admits defeat, ARS troops forward to fund commercialization of epinephrine nasal spray
ARS Pharmaceuticals is backing onto Nasdaq through a reverse merger with Silverback Therapeutics to bag cash to commercialize an epinephrine nasal spray and win market share from the incumbent EpiPen.
Stream now with KPBS Passport on KPBS+ / Watch Sunday, Jan. 4, 2026 at 8 p.m. on KPBS 2 Award-winning wildlife cameraman Vianet Djenguet has held a deep spiritual connection with gorillas since he was ...
SBT6290 Shown to Activate Myeloid Cells and Drive Anti-tumor Effects in Nectin4-expressing Solid Tumors “SBT6290 showcases the versatility of our ImmunoTAC platform and along with our lead program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results